$10.720
-0.809 (-7.55%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
Retension Pharmaceuticals, Inc. Common Stock 株は買うべき?
Retension Pharmaceuticals may not be a good buy right now due to its current price of $11.44, which is significantly below the analyst's target of $55, but the recent 5-day decline of 19.66% raises concerns about short-term performance. The company has reported negative net income in the last four quarters, with a loss of $4,170,589 in Q2 2026, indicating ongoing financial struggles.
RTSN の株価は Thursday に $10.72 で引け、その前に下落 -7.55%
Retension Pharmaceuticals, Inc. Common Stock (RTSN) last closed at $10.7200003, losing -7.55%. These facts feed the 1-day and 1-week RTSN price prediction above.
予想の要因
Retension Pharmaceuticals, Inc. Common Stock(RTSN)の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Seasonality
Bearish
RTSN の季節性分析
関連記事
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。